QIMR Berghofer

Preliminary findings of a Phase I safety and bioimaging trial of KB004 (ifabotuzumab) in patients with glioblastoma

Authors Gan, Hui; Cher, Lawrence; Inglis, Po; Lwin, Zarnie; Lau, Eddie; Ackermann, Uwe; Coombs, Nicole; Remen, Kirsten; Guo, Nancy; Lee, Sze Ting; Gong, Sylvia; Palmer, Jodie; Pathmaraj, Kunthi; O'Keefe, Graeme; Scott, Fiona; Day, Bryan; Boyd, Andrew; Thomas, Paul; Durrant, Cameron; Scott, Andrew
Journal CANCER RESEARCH
Pages 6-6
Volume 79
Date 1/07/2019
Grant ID
Funding Body
URL http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1158/1538-7445.AM2019-CT063